CA125- and tumor-specific T-cell responses correlate with prolonged survival in oregovomab-treated recurrent ovarian cancer patients - Concepedia

Concepedia

Publication | Closed Access

CA125- and tumor-specific T-cell responses correlate with prolonged survival in oregovomab-treated recurrent ovarian cancer patients

89

Citations

20

References

2004

Year

Alan N. Gordon, Birgit C. Schultes, Holly H. Gallion, Robert P. Edwards, Theresa L. Whiteside, J Cermák, Christopher F. Nicodemus

Gynecologic Oncology

Cancer ImmunosurveillanceTumor-specific T-cell ResponsesMedicineImmunologyImmune Checkpoint InhibitorProlonged SurvivalCancer TreatmentOncologyCell BiologyOvarian Cancer

References

	Year	Citations

Page 1